Indigent Women With Breast Cancer Are Often Not Referred for Breast Reconstruction

Publication
Article
OncologyONCOLOGY Vol 10 No 11
Volume 10
Issue 11

The option of reconstruction after mastectomy for breast cancer is often not discussed with indigent patients, according to a study presented at the 65th Annual Meeting of the American Society of Plastic and Reconstructive Surgeons (ASPRS) held in Dallas, Texas.

The option of reconstruction after mastectomy for breast canceris often not discussed with indigent patients, according to astudy presented at the 65th Annual Meeting of the American Societyof Plastic and Reconstructive Surgeons (ASPRS) held in Dallas,Texas.

The retrospective review, which covered a period of 10 years,showed that fewer than 20% of indigent women were offered breastreconstruction and only 4.5% actually underwent the procedure.

"The number of women referred for reconstruction after mastectomyamong indigent patients was extremely low," said plasticsurgeon Sharon Kalina, md, Loma Linda University Medical Center,Loma Linda, California, one of the clinical investigators. "Eventhough women may not choose to have breast reconstruction, theyhave a right to know it is available to them even in the yearsto come."

The study, conducted at Riverside General Hospital, included 155indigent patients treated for breast cancer between 1984 and 1994.The average age of the patients was 52 years. Although the groupincluded African-American (10%), Hispanic (29%), and other ethnicgroups (6%), more than half the women (55%) were Caucasian.

Almost all (96.8%) of the patients underwent mastectomy, but only30 patients (19.4%) were offered reconstruction by the generalsurgeon or oncologist. Among the subgroup offered reconstruction,four were not referred due to severe medical problems or lackof interest. Of the 26 patients referred for reconstruction, only23 (14.8%) kept their initial appointment and 7 patients (4.5%)underwent reconstruction. Of the remaining 16 patients, 3 declinedreconstruction, 2 had severe medical or psychiatric problems,and 11 were totally lost to follow-up.

Many of the women were overweight, and some were heavy smokers.Others were undergoing chemotherapy or radiation therapy. Whilethese conditions may have influenced the decision, they shouldnot have ruled out the possibility of breast reconstruction forall these women.

"The first thing we have to do is to improve awareness ofthe situation," said Dr. Kalina. "Even if some of thesespecial conditions may be present, the patient should have anopportunity to discuss breast reconstruction with the plasticsurgeon."

In some states, insurance companies are now required to coverbreast reconstruction after mastectomy for breast cancer. Whenpatients are given the option of breast reconstruction, they areable to discuss their choices with a plastic surgeon and makethe most appropriate decision for themselves.

"At the very least, the patient should be provided with aprescription for a prosthesis to allow them some measure of normalappearance," said Dr. Kalina. "They also need to bereferred to local support groups for assistance in coping withthe emotional impact of the disease and the recovery process."

In addition, indigent patients need to be educated about the importanceof keeping medical appointments to complete medical treatments.Dr. Kalina indicated that additional research needs to be doneto investigate the reasons for poor follow-up of medical appointmentsamong this patient population.

Recent Videos
Heather Zinkin, MD, states that reflexology improved pain from chemotherapy-induced neuropathy in patients undergoing radiotherapy for breast cancer.
Study findings reveal that patients with breast cancer reported overall improvement in their experience when receiving reflexology plus radiotherapy.
Patients undergoing radiotherapy for breast cancer were offered 15-minute nurse-led reflexology sessions to increase energy and reduce stress and pain.
Whole or accelerated partial breast ultra-hypofractionated radiation in older patients with early breast cancer may reduce recurrence with low toxicity.
Ultra-hypofractionated radiation in those 65 years or older with early breast cancer yielded no ipsilateral recurrence after a 10-month follow-up.
The unclear role of hypofractionated radiation in older patients with early breast cancer in prior trials incentivized research for this group.
Patients with HR-positive, HER2-positive breast cancer and high-risk features may derive benefit from ovarian function suppression plus endocrine therapy.
Paolo Tarantino, MD discusses updated breast cancer trial findings presented at ESMO 2024 supporting the use of agents such as T-DXd and ribociclib.
Paolo Tarantino, MD, discusses the potential utility of agents such as datopotamab deruxtecan and enfortumab vedotin in patients with breast cancer.
Paolo Tarantino, MD, highlights strategies related to screening and multidisciplinary collaboration for managing ILD in patients who receive T-DXd.